Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Cash from Investing Activities (2016 - 2025)

Abeona Therapeutics has reported Cash from Investing Activities over the past 14 years, most recently at $9.6 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $9.6 million for Q4 2025, down 49.39% from a year ago — trailing twelve months through Dec 2025 was $105.0 million (up 367.66% YoY), and the annual figure for FY2025 was $105.0 million, up 367.66%.
  • Cash from Investing Activities for Q4 2025 was $9.6 million at Abeona Therapeutics, up from -$64.6 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for ABEO hit a ceiling of $155.9 million in Q2 2025 and a floor of -$64.6 million in Q3 2025.
  • Median Cash from Investing Activities over the past 5 years was $3.2 million (2023), compared with a mean of $5.4 million.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 483.84% in 2021 and later plummeted 1236.63% in 2023.
  • Abeona Therapeutics' Cash from Investing Activities stood at $8.0 million in 2021, then crashed by 416.16% to -$25.3 million in 2022, then soared by 145.59% to $11.5 million in 2023, then surged by 63.73% to $18.9 million in 2024, then plummeted by 49.39% to $9.6 million in 2025.
  • The last three reported values for Cash from Investing Activities were $9.6 million (Q4 2025), -$64.6 million (Q3 2025), and $155.9 million (Q2 2025) per Business Quant data.